Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Brain Neoplasms

3,4-methylenedioxyamphetamine has been researched along with Brain Neoplasms in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kaye, EC1
Kegel, A1
Weber, M1
Cartwright, C1
Spraker-Perlman, H1
Robinson, GW1
Baker, JN1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Brain Neoplasms

ArticleYear
Food Is Love: Partnering With Families to Provide Nourishment at the End of Life.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 06-01, Volume: 38, Issue:16

    Topics: Administration, Cutaneous; Brain Neoplasms; Death; Fluid Therapy; Grief; Humans; Love; Massage; Moth

2020